Viewing Study NCT04895735


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT04895735
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-28
First Post: 2021-05-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module